Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age

References

• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689.
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–1250.
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome: the Study of Women’s Health across the Nation. Arch Intern Med. 2008;168(14):1568–1575.
   PubMedGoogle Scholar
• Thurston RC, Sowers MR, Sternfeld B, et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women’s health across the nation. Am J Epidemiol. 2009;170(6):766–774.
   PubMedGoogle Scholar
• Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ. 2012;344:e402.
   PubMed Web of Science ®Google Scholar
• Thurston RC, El Khoudary SR, Tepper PG, et al. Trajectories of vasomotor symptoms and carotid intima media thickness in the study of women’s health across the nation. Stroke. 2016;47(1):12–17.
   PubMed Web of Science ®Google Scholar
• Lensen S, Archer D, Bell RJ, et al. A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. Menopause. 2021;28(8):852–858.
   PubMed Web of Science ®Google Scholar
• Lensen S, Bell RJ, Carpenter JS, et al. A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. Menopause. 2021;28(8):859–866.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Palma F, Romani C, et al. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? Gynecol Endocrinol. 2015;31(5):359–362.
   PubMed Web of Science ®Google Scholar
• Biglia N, Cagnacci A, Gambacciani M, et al. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017;20(4):306–312.
   PubMed Web of Science ®Google Scholar
• Wolff EF, He Y, Black DM, et al. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Fertil Steril. 2013;99(5):1385–1391.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Chang Y, Barinas-Mitchell E, et al. Menopausal hot flashes and carotid intima media thickness among midlife women. Stroke. 2016;47(12):2910–2915.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Colpani V, et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2016;11(6):e0157417.
   PubMed Web of Science ®Google Scholar
• Szmuilowicz ED, Manson JE, Rossouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011;18(6):603–610.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Aslanidou Vlachos HE, et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc. 2021;10:e017416.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Cannoletta M, Caretto S, et al. Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. Menopause. 2011;18(3):273–278.
   PubMedGoogle Scholar
• Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94(8):2692–2701.
   PubMed Web of Science ®Google Scholar
• Gupta P, Harte AL, da Silva NF, et al. Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status. Menopause. 2007;14(6):1031–1038.
   PubMedGoogle Scholar
• Thurston RC, Christie IC, Matthews KA. Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause. 2010;17(3):456–461.
   PubMed Web of Science ®Google Scholar
• Gast GC, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51(6):1492–1498.
   PubMed Web of Science ®Google Scholar
• Sadeghi M, Khalili M, Pourmoghaddas M, et al. The correlation between blood pressure and hot flashes in menopausal women. ARYA Atheroscler. 2012;8:32–35.
   PubMedGoogle Scholar
• Flint AC, Conell C, Ren X, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381(3):243–251.
   PubMed Web of Science ®Google Scholar
• Gallicchio L, Miller SR, Zacur H, et al. Hot flashes and blood pressure in midlife women. Maturitas. 2010;65(1):69–674.
   PubMedGoogle Scholar
• Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–358.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Xholli A, Sclauzero M, et al. Vaginal atrophy across the menopausal age: results from the ANGEL study. Climacteric. 2019;22(1):85–89.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Sclauzero M, Meriggiola C, et al. Lower urinary tract symptoms and their relation to vaginal atrophy in women across the menopausal age span. Results from the ANGEL multicentre observational study. Maturitas. 2020;140:8–13.
   PubMed Web of Science ®Google Scholar
• ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925–1938.
   PubMed Web of Science ®Google Scholar
• Palma F, Xholli A, Cagnacci A. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas. 2018; 108:18–23.
   PubMed Web of Science ®Google Scholar
• Cannoletta M, Cagnacci A. Modification of blood pressure in postmenopausal women: role of hormone replacement therapy. Int J Womens Health. 2014;11:745–757.
   Google Scholar
• Graham ME, Herbert WG, Song SD, et al. Gut and vaginal microbiomes on steroids: implications for women’s health. Trends Endocrinol Metab. 2021;32:554–565.
   PubMedGoogle Scholar
• Huang J, Shan W, Li F, et al. Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice. Aging (Albany NY). 2021;13(5):7589–7607.
   PubMedGoogle Scholar
• Guo Y, Li X, Wang Z, et al. Gut microbiota dysbiosis in human hypertension: a systematic review of observational studies. Front Cardiovasc Med. 2021;8:650227.
   PubMed Web of Science ®Google Scholar